[Prehospital point of care testing of biomarkers has diagnostic value in relation to acute myocardial infarction].
Prehospital point of care testing (POCT) of biomarkers may be a valuable tool for optimizing prehospital diagnosis. We report the status of prehospital POCT in relation to acute myocardial infarction (AMI). No randomized studies have been performed. Eight observational studies collectively show added diagnostic value of prehospital POCT in relation to AMI. The revised European NSTEMI guidelines focus on early risk assessment in relevant timing of reperfusion strategy. We anticipate that prehospital POCT will be central in NSTEMI care in the near future.
Hjertemedicinsk Afdeling B, Aarhus Universitetshospital, Brendstrupgaardsvej 100, 8200 Aarhus N, Denmark. carstengaard@hotmail.com
Carsten
C
Stengaard
Jacob
J
Thorsted Sørensen
Christian Juhl
CJ
Terkelsen
D015415:Biomarkers / Q000097:blood*; D052279:Creatine Kinase, MB Form / Q000097:blood; D004632:Emergency Medical Services / Q000379:methods*; D006020:Glycopeptides / Q000097:blood; D006801:Humans; D009203:Myocardial Infarction / Q000097:blood / Q000175:diagnosis*; D009211:Myoglobin / Q000097:blood; D019095:Point-of-Care Systems; D013997:Time Factors; D061665:Time-to-Treatment; D019210:Troponin I / Q000097:blood; D020107:Troponin T / Q000097:blood
D015415:Biomarkers; D006020:Glycopeptides; D009211:Myoglobin; D019210:Troponin I; D020107:Troponin T; C048197:copeptins; D052279:Creatine Kinase, MB Form